搜索临床试验以:聚乙二醇干扰素λ-1A
总计1183个结果
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Thomas OlenckiSchering-Plough终止
-
Merck Sharp & Dohme LLC完全的
-
Chinese University of Hong KongHoffmann-La Roche完全的
-
Debiopharm International SA完全的丙型肝炎罗马尼亚, 意大利, 匈牙利, 台湾, 火鸡, 比利时, 西班牙, 德国, 澳大利亚, 法国, 美国, 英国, 波兰, 波多黎各
-
Timothy Morgan, MDVertex Pharmaceuticals Incorporated撤销
-
International Food Policy Research InstituteCornell University; World Vision; Micronutrient Initiative完全的
-
Beth Israel Medical Center终止
-
University of ValenciaHoffmann-La Roche未知慢性丙型肝炎 | Co-Infection HIV-HCV西班牙
-
Shandong Cancer Hospital and Institute招聘中
-
University Hospital TuebingenDermatologic Cooperative Oncology Group完全的
-
Yonsei University完全的
-
Enyo Pharma完全的
-
Emory UniversityCURE Childhood Cancer, Inc.完全的
-
National Cancer Institute (NCI)National Institute of Allergy and Infectious Diseases (NIAID)完全的
-
Institute of Hematology & Blood Diseases Hospital...招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)终止
-
Gilead Sciences完全的
-
Hoffmann-La Roche完全的
-
Shanghai General Hospital, Shanghai Jiao Tong University...完全的
-
HanAll BioPharma Co., Ltd.完全的
-
University of Auckland, New ZealandSingapore Institute for Clinical Sciences; Massey University; AgResearch; The Riddet Institute完全的
-
M.D. Anderson Cancer CenterSchering-Plough终止
-
National Institute on Drug Abuse (NIDA)Organization to Achieve Solutions in Substance Abuse (OASIS)完全的
-
Ochsner Health SystemNewLink Genetics Corporation未知
-
Tibotec BVBA完全的
-
Institute of Hematology & Blood Diseases Hospital...招聘中
-
John MascarenhasRoche Pharma AG; The Leukemia and Lymphoma Society完全的
-
Merck Sharp & Dohme LLC完全的
-
ANRS, Emerging Infectious DiseasesRoche Pharma AG未知
-
University of Modena and Reggio EmiliaMerck Sharp & Dohme LLC未知